{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:42:00Z","timestamp":1794411720604,"version":"4.9.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3600100, 2019YFA0903802"],"award-info":[{"award-number":["2022YFC3600100, 2019YFA0903802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Noncoding RNAs such as circular RNAs (circRNAs) are abundant in the human body and influence the occurrence and development of various diseases. Non-small cell lung cancer (NSCLC) is one of the most common malignant cancers. Information on the functions and mechanism of circRNAs in lung cancer is limited; thus, the topic needs more exploration. The purpose of this study was to identify aberrantly expressed circRNAs in lung cancer, unravel their roles in NSCLC progression, and provide new targets for lung cancer diagnosis and therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>High-throughput sequencing was used to analyze differential circRNA expression in patients with lung cancer. qRT\u2012PCR was used to determine the level of circHERC1 in lung cancer tissues and plasma samples. Gain- and loss-of-function experiments were implemented to observe the impacts of circHERC1 on the growth, invasion, and metastasis of lung cancer cells in vitro and in vivo. Mechanistically, dual luciferase reporter assays, fluorescence in situ hybridization (FISH), RNA immunoprecipitation (RIP) and RNA pull-down experiments were performed to confirm the underlying mechanisms of circHERC1. Nucleocytoplasmic localization of FOXO1 was determined by nucleocytoplasmic isolation and immunofluorescence. The interaction of circHERC1 with FOXO1 was verified by RNA pull-down, RNA immunoprecipitation (RIP) and western blot assays. The proliferation and migration of circHERC1 in vivo were verified by subcutaneous and tail vein injection in nude mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CircHERC1 was significantly upregulated in lung cancer tissues and cells, ectopic expression of circHERC1 strikingly facilitated the proliferation, invasion and metastasis, and inhibited the apoptosis of lung cancer cells in vitro and in vivo. However, knockdown of circHERC1 exerted the opposite effects. CircHERC1 was mainly distributed in the cytoplasm. Further mechanistic research indicated that circHERC1 acted as a competing endogenous RNA of miR-142-3p to relieve the repressive effect of miR-142-3p on its target HMGB1, activating the MAPK\/ERK and NF-\u03baB pathways and promoting cell migration and invasion. More importantly, we found that circHERC1 could bind FOXO1 and sequester it in the cytoplasm, adjusting the feedback AKT pathway. The accumulation of FOXO1 in the cytosol and nuclear exclusion promoted cell proliferation and inhibited apoptosis. CircHERC1 is a new circRNA that promotes tumor function in NSCLC and may serve as a potential prognostic biomarker and therapeutic target for NSCLC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CircHERC1 is a new circRNA that promotes tumor function in NSCLC and may serve as a potential diagnosis biomarker and therapeutic target for NSCLC. Our findings indicate that circHERC1 facilitates the invasion and metastasis of NSCLC cells by regulating the miR-142-3p\/HMGB1 axis and activating the MAPK\/ERK and NF-\u03baB pathways. In addition, circHERC1 can promote cell proliferation and inhibit apoptosis by sequestering FOXO1 in the cytoplasm to regulate AKT activity and BIM transcription.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12943-023-01888-7","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T04:02:28Z","timestamp":1699243348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis"],"prefix":"10.1186","volume":"22","author":[{"given":"Yumeng","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiling","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"key":"1888_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"1888_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"1888_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","volume":"157","author":"TR Cech","year":"2014","unstructured":"Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 2014;157:77\u201394.","journal-title":"Cell"},{"key":"1888_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.trecan.2020.01.012","volume":"6","author":"J Li","year":"2020","unstructured":"Li J, Sun D, Pu W, Wang J, Peng Y. Circular RNAs in Cancer: Biogenesis, function, and clinical significance. Trends Cancer. 2020;6:319\u201336.","journal-title":"Trends Cancer"},{"key":"1888_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, Wu YM, Dhanasekaran SM, Engelke CG, Cao X, et al. The Landscape of circular RNA in Cancer. Cell. 2019;176:869\u2013881e813.","journal-title":"Cell"},{"key":"1888_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32:453\u201361.","journal-title":"Nat Biotechnol"},{"key":"1888_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","volume":"12","author":"LL Chen","year":"2015","unstructured":"Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12:381\u20138.","journal-title":"RNA Biol"},{"key":"1888_CR8","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1093\/nar\/gkv045","volume":"43","author":"S Petkovic","year":"2015","unstructured":"Petkovic S, Muller S. RNA circularization strategies in vivo and in vitro. Nucleic Acids Res. 2015;43:2454\u201365.","journal-title":"Nucleic Acids Res"},{"key":"1888_CR9","doi-asserted-by":"publisher","first-page":"e1003777","DOI":"10.1371\/journal.pgen.1003777","volume":"9","author":"J Salzman","year":"2013","unstructured":"Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9:e1003777.","journal-title":"PLoS Genet"},{"key":"1888_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2019.01.025","volume":"176","author":"S Chen","year":"2019","unstructured":"Chen S, Huang V, Xu X, Livingstone J, Soares F, Jeon J, Zeng Y, Hua JT, Petricca J, Guo H, et al. Widespread and functional RNA circularization in localized Prostate Cancer. Cell. 2019;176:831\u2013843e822.","journal-title":"Cell"},{"key":"1888_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/cdd.2016.133","volume":"24","author":"WW Du","year":"2017","unstructured":"Du WW, Fang L, Yang W, Wu N, Awan FM, Yang Z, Yang BB. Induction of Tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2017;24:357\u201370.","journal-title":"Cell Death Differ"},{"key":"1888_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cell.2014.09.001","volume":"159","author":"XO Zhang","year":"2014","unstructured":"Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL, Yang L. Complementary sequence-mediated exon circularization. Cell. 2014;159:134\u201347.","journal-title":"Cell"},{"key":"1888_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","volume":"160","author":"SJ Conn","year":"2015","unstructured":"Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA, Goodall GJ. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160:1125\u201334.","journal-title":"Cell"},{"key":"1888_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384\u20138.","journal-title":"Nature"},{"key":"1888_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17:272\u201383.","journal-title":"Nat Rev Genet"},{"key":"1888_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygeno.2017.06.005","volume":"109","author":"S Huang","year":"2017","unstructured":"Huang S, Yang B, Chen BJ, Bliim N, Ueberham U, Arendt T, Janitz M. The emerging role of circular RNAs in transcriptome regulation. Genomics. 2017;109:401\u20137.","journal-title":"Genomics"},{"key":"1888_CR17","doi-asserted-by":"crossref","unstructured":"Man W, Cui Y, Li J, Li Y, Jin J, Jin Y, Wu X, Zhong R, Li X, Yao H et al. circTAB2 inhibits lung cancer proliferation, migration and invasion by sponging miR-3142 to upregulate GLIS2. Apoptosis 2023, 28:471\u2013484.","DOI":"10.1007\/s10495-022-01805-1"},{"key":"1888_CR18","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/nar\/gkw027","volume":"44","author":"WW Du","year":"2016","unstructured":"Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44:2846\u201358.","journal-title":"Nucleic Acids Res"},{"key":"1888_CR19","doi-asserted-by":"publisher","first-page":"12429","DOI":"10.1038\/ncomms12429","volume":"7","author":"LM Holdt","year":"2016","unstructured":"Holdt LM, Stahringer A, Sass K, Pichler G, Kulak NA, Wilfert W, Kohlmaier A, Herbst A, Northoff BH, Nicolaou A, et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and Atherosclerosis in humans. Nat Commun. 2016;7:12429.","journal-title":"Nat Commun"},{"key":"1888_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","volume":"19","author":"M Lei","year":"2020","unstructured":"Lei M, Zheng G, Ning Q, Zheng J, Dong D. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020;19:30.","journal-title":"Mol Cancer"},{"key":"1888_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19:172.","journal-title":"Mol Cancer"},{"key":"1888_CR22","first-page":"1402","volume":"38","author":"WW Du","year":"2017","unstructured":"Du WW, Yang W, Chen Y, Wu ZK, Foster FS, Yang Z, Li X, Yang BB. Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses. Eur Heart J. 2017;38:1402\u201312.","journal-title":"Eur Heart J"},{"key":"1888_CR23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/hep.31493","volume":"73","author":"Y Xu","year":"2021","unstructured":"Xu Y, Leng K, Yao Y, Kang P, Liao G, Han Y, Shi G, Ji D, Huang P, Zheng W, et al. A circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, contributes to Cholangiocarcinoma Progression, induces angiogenesis, and disrupts vascular endothelial barriers. Hepatology. 2021;73:1419\u201335.","journal-title":"Hepatology"},{"key":"1888_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1888_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12943-022-01599-5","volume":"21","author":"L Meng","year":"2022","unstructured":"Meng L, Zhang Y, Wu P, Li D, Lu Y, Shen P, Yang T, Shi G, Chen Q, Yuan H, et al. CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2. Mol Cancer. 2022;21:121.","journal-title":"Mol Cancer"},{"key":"1888_CR26","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1093\/nar\/gkl151","volume":"34","author":"H Suzuki","year":"2006","unstructured":"Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A, Mayeda A. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res. 2006;34:e63.","journal-title":"Nucleic Acids Res"},{"key":"1888_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2015.06.003","volume":"365","author":"S Qu","year":"2015","unstructured":"Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, Sun W, Dou K, Li H. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365:141\u20138.","journal-title":"Cancer Lett"},{"key":"1888_CR28","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1172\/JCI61492","volume":"122","author":"W Long","year":"2012","unstructured":"Long W, Foulds CE, Qin J, Liu J, Ding C, Lonard DM, Solis LM, Wistuba II, Qin J, Tsai SY, et al. ERK3 signals through SRC-3 coactivator to promote human Lung cancer cell invasion. J Clin Invest. 2012;122:1869\u201380.","journal-title":"J Clin Invest"},{"key":"1888_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature23297","volume":"548","author":"P Nieto","year":"2017","unstructured":"Nieto P, Ambrogio C, Esteban-Burgos L, Gomez-Lopez G, Blasco MT, Yao Z, Marais R, Rosen N, Chiarle R, Pisano DG, et al. A braf kinase-inactive mutant induces lung adenocarcinoma. Nature. 2017;548:239\u201343.","journal-title":"Nature"},{"key":"1888_CR30","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1158\/1078-0432.CCR-15-1374","volume":"22","author":"KP Zeligs","year":"2016","unstructured":"Zeligs KP, Neuman MK, Annunziata CM. Molecular pathways: the balance between Cancer and the Immune System challenges the therapeutic specificity of Targeting Nuclear factor-kappab signaling for Cancer Treatment. Clin Cancer Res. 2016;22:4302\u20138.","journal-title":"Clin Cancer Res"},{"key":"1888_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-022-01013-y","volume":"7","author":"M Yuan","year":"2022","unstructured":"Yuan M, Zhao Y, Arkenau HT, Lao T, Chu L, Xu Q. Signal pathways and precision therapy of small-cell Lung cancer. Signal Transduct Target Ther. 2022;7:187.","journal-title":"Signal Transduct Target Ther"},{"key":"1888_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41392-021-00788-w","volume":"6","author":"C Xue","year":"2021","unstructured":"Xue C, Li G, Lu J, Li L. Crosstalk between circRNAs and the PI3K\/AKT signaling pathway in cancer progression. Signal Transduct Target Ther. 2021;6:400.","journal-title":"Signal Transduct Target Ther"},{"key":"1888_CR33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/path.5144","volume":"246","author":"Y Li","year":"2018","unstructured":"Li Y, Deng L, Zhao X, Li B, Ren D, Yu L, Pan H, Gong Q, Song L, Zhou X, Dai T. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell Lung cancer cells by activating the NF-kappaB pathway. J Pathol. 2018;246:366\u201378.","journal-title":"J Pathol"},{"key":"1888_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cell.2012.05.017","volume":"150","author":"E Elkayam","year":"2012","unstructured":"Elkayam E, Kuhn CD, Tocilj A, Haase AD, Greene EM, Hannon GJ, Joshua-Tor L. The structure of human argonaute-2 in complex with miR-20a. Cell. 2012;150:100\u201310.","journal-title":"Cell"},{"key":"1888_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15:509\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1888_CR36","doi-asserted-by":"crossref","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife 2015, 4.","DOI":"10.7554\/eLife.05005"},{"key":"1888_CR37","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127\u201331.","journal-title":"Nucleic Acids Res"},{"key":"1888_CR38","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41419-021-04150-4","volume":"12","author":"Y Ren","year":"2021","unstructured":"Ren Y, Cao L, Wang L, Zheng S, Zhang Q, Guo X, Li X, Chen M, Wu X, Furlong F, et al. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell Lung cancer cells via NFkappaB signaling. Cell Death Dis. 2021;12:858.","journal-title":"Cell Death Dis"},{"key":"1888_CR39","doi-asserted-by":"crossref","unstructured":"Tanuma SI, Oyama T, Okazawa M, Yamazaki H, Takao K, Sugita Y, Amano S, Abe T, Sakagami H. A dual anti-inflammatory and anti-proliferative 3-Styrylchromone derivative synergistically enhances the Anti-cancer effects of DNA-Damaging agents on Colon Cancer cells by targeting HMGB1-RAGE-ERK1\/2 signaling. Int J Mol Sci 2022, 23.","DOI":"10.3390\/ijms23073426"},{"key":"1888_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A. AKT\/PKB signaling: navigating the network. Cell. 2017;169:381\u2013405.","journal-title":"Cell"},{"key":"1888_CR41","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1158\/0008-5472.CAN-13-1729","volume":"74","author":"A Lin","year":"2014","unstructured":"Lin A, Piao HL, Zhuang L, Sarbassov dos D, Ma L, Gan B. FoxO transcription factors promote AKT Ser473 phosphorylation and renal Tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway. Cancer Res. 2014;74:1682\u201393.","journal-title":"Cancer Res"},{"key":"1888_CR42","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/CIRCRESAHA.115.303227","volume":"115","author":"H Dharaneeswaran","year":"2014","unstructured":"Dharaneeswaran H, Abid MR, Yuan L, Dupuis D, Beeler D, Spokes KC, Janes L, Sciuto T, Kang PM, Jaminet SS, et al. FOXO1-mediated activation of akt plays a critical role in vascular homeostasis. Circ Res. 2014;115:238\u201351.","journal-title":"Circ Res"},{"key":"1888_CR43","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","volume":"185","author":"CX Liu","year":"2022","unstructured":"Liu CX, Chen LL. Circular RNAs: characterization, cellular roles, and applications. Cell. 2022;185:2016\u201334.","journal-title":"Cell"},{"key":"1888_CR44","doi-asserted-by":"publisher","first-page":"215810","DOI":"10.1016\/j.canlet.2022.215810","volume":"544","author":"J Li","year":"2022","unstructured":"Li J, Zhang Q, Jiang D, Shao J, Li W, Wang C. CircRNAs in lung cancer- role and clinical application. Cancer Lett. 2022;544:215810.","journal-title":"Cancer Lett"},{"key":"1888_CR45","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/s41388-022-02232-x","volume":"41","author":"XY Guo","year":"2022","unstructured":"Guo XY, Liu TT, Zhu WJ, Liu HT, Zhang GH, Song L, Zhao RN, Chen X, Gao P. CircKDM4B suppresses Breast cancer progression via the miR-675\/NEDD4L axis. Oncogene. 2022;41:1895\u2013906.","journal-title":"Oncogene"},{"key":"1888_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-018-0892-z","volume":"17","author":"F Xie","year":"2018","unstructured":"Xie F, Li Y, Wang M, Huang C, Tao D, Zheng F, Zhang H, Zeng F, Xiao X, Jiang G. Circular RNA BCRC-3 suppresses Bladder cancer proliferation through miR-182-5p\/p27 axis. Mol Cancer. 2018;17:144.","journal-title":"Mol Cancer"},{"key":"1888_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13577-019-00258-0","volume":"32","author":"C Jin","year":"2019","unstructured":"Jin C, Xiao L, Zhou Z, Zhu Y, Tian G, Ren S. MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma. Hum Cell. 2019;32:437\u201346.","journal-title":"Hum Cell"},{"key":"1888_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/jcp.29481","volume":"236","author":"S Liu","year":"2021","unstructured":"Liu S, Yang N, Jiang X, Wang J, Dong J, Gao Y. FUS-induced circular RNA ZNF609 promotes tumorigenesis and progression via sponging mir-142-3p in Lung cancer. J Cell Physiol. 2021;236:79\u201392.","journal-title":"J Cell Physiol"},{"key":"1888_CR49","doi-asserted-by":"publisher","first-page":"120268","DOI":"10.1016\/j.lfs.2021.120268","volume":"291","author":"P Sharma","year":"2022","unstructured":"Sharma P, Yadav P, Jain RP, Bera AK, Karunagaran D. Mir-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human Cervical cancer cells. Life Sci. 2022;291:120268.","journal-title":"Life Sci"},{"key":"1888_CR50","doi-asserted-by":"publisher","first-page":"13613","DOI":"10.1073\/pnas.0405454101","volume":"101","author":"M Aoki","year":"2004","unstructured":"Aoki M, Jiang H, Vogt PK. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and akt oncoproteins. Proc Natl Acad Sci U S A. 2004;101:13613\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1888_CR51","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1136\/annrheumdis-2013-203610","volume":"74","author":"AM Grabiec","year":"2015","unstructured":"Grabiec AM, Angiolilli C, Hartkamp LM, van Baarsen LG, Tak PP, Reedquist KA. JNK-dependent downregulation of FoxO1 is required to promote the survival of fibroblast-like synoviocytes in rheumatoid arthritis. Ann Rheum Dis. 2015;74:1763\u201371.","journal-title":"Ann Rheum Dis"},{"key":"1888_CR52","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1158\/1078-0432.CCR-10-1891","volume":"17","author":"SR Boreddy","year":"2011","unstructured":"Boreddy SR, Pramanik KC, Srivastava SK. Pancreatic Tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K\/AKT\/FOXO pathway. Clin Cancer Res. 2011;17:1784\u201395.","journal-title":"Clin Cancer Res"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-023-01888-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T05:04:42Z","timestamp":1699247082000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-023-01888-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1888"],"URL":"https:\/\/doi.org\/10.1186\/s12943-023-01888-7","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"19 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies using human tissues were authorized by the Ethics Committee of Chinese PLA General Hospital and the Ethics Committee of Beijing Institute of Biotechnology (Approval number: AF\/SC-08\/02.216), and performed in accordance with the principles of Declaration of Helsinki. The animal study was approved by the Animal Ethic Review Committees of Beijing Institute of Biotechnology (Approval number: IACUC-DXZW-2021-021). All animal experiments were strictly implemented in compliance with the NIH Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of manuscript in Molecular Cancer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}